3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
3
Breast Neoplasms
2
Urologic Neoplasms
1
Thyroid Neoplasms
1
Soft Tissue Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma, Embryonal
1
Rhabdomyosarcoma, Alveolar
1
Rhabdomyosarcoma
1
Recurrence
1
Pharyngeal Neoplasms
1
Neurofibromatosis 2
1
Neoplasms, Mesothelial
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Mouth Neoplasms
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphangioleiomyomatosis
1
Lung Neoplasms
1
Kidney Neoplasms
1
Erdheim-Chester Disease
1
Endometrial Adenocarcinoma
1
Endocrine Gland Neoplasms
1
Colonic Neoplasms
1
Castleman Disease
1
Carcinoma, Transitional Cell
1
Interventions
Cisplatin
4
Radiotherapy
3
Cetuximab
3
pembrolizumab
2
Surveys and Questionnaires
2
Carboplatin
2
olaparib
1
niraparib
1
fludarabine
1
dostarlimab
1
cemiplimab
1
calcipotriene
1
avelumab
1
atezolizumab
1
aldesleukin
1
Watchful Waiting
1
Tiragolumab
1
Standard of Care
1
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Image-Guided
1
Platinum
1
Phlebotomy
1
Paclitaxel
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Fluorouracil
1
Fluorodeoxyglucose F18
1
Docetaxel
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Squamous Cell
×
temsirolimus
×
30 days
×
Clear all
No trials found.